← Back to contracts

Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)

US · MD National Institutes of Health / National Center for Complementary and Integrative Health (NCCIH) grant open #PAR-24-312
Response due Jul 14, 2026 · 00:00 UTC

Summary

The National Center for Complementary and Integrative Health (NCCIH), part of NIH/HHS, is soliciting applications for a Clinical Coordinating Center to support multi-site investigator-initiated clinical trials of natural products. The funding mechanism is a collaborative UG3/UH3 award, which involves a phased trial design requiring a clinical trial. This is a federal grant opportunity posted on Grants.gov targeting research institutions capable of coordinating complex, multi-site clinical research on natural products.

What they want

Applicants must establish and operate a Clinical Coordinating Center to support NCCIH-funded multi-site investigator-initiated clinical trials focused on natural products. The award uses a UG3/UH3 phased cooperative agreement mechanism, with the UG3 phase covering planning/feasibility and the UH3 phase covering full trial implementation. A clinical trial is required as part of the application and award.
Technical requirements
  • Must establish a Clinical Coordinating Center for multi-site trial coordination
  • Clinical trial required as part of application (not optional)
  • Phased UG3 (planning/feasibility) and UH3 (full trial implementation) cooperative agreement structure
  • Collaborative application mechanism required
  • Trials must focus on natural products
Key personnel
  • Principal Investigator (multi-PD/PI collaborative model expected)
  • Clinical Trial Coordinator
  • Biostatistician

How they evaluate

  • Scientific and technical merit reviewed by NIH Study Section
  • Innovation and significance of natural products clinical trial
  • Approach and feasibility of multi-site coordination
  • Qualifications and experience of investigative team
  • Environment and institutional support
Submission: Electronic submission via Grants.gov and NIH eRA Commons

Risks & flags

  • No dollar value disclosed, making budget competitiveness difficult to assess
  • UG3/UH3 phased mechanism is highly specific and limits eligible applicants to those experienced with NIH cooperative agreement trial structures
  • Long open window (Oct 2024 – Jul 2026) with rolling submissions may reflect difficulty attracting qualified applicants or ongoing program with existing relationships

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541711
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Clinical Coordinating Center for NCCIH Mul…
Due Jul 14
Onboard